Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in Spinocerebellar Ataxia Type 2
NCT03347344Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of riluzole in Spinocerebellar Ataxia Type 2 (SCA2), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2018; status: completed.
02
Drugs
riluzole
03
Conditions
Spinocerebellar Ataxia Type 2 (SCA2)
Beyond the preview
Go deeper on NCT03347344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03347344.